Clinical Topics & News

Superficial Pyoderma Gangrenosum Treated With Infliximab: A Case Report

Author and Disclosure Information

We report a case of superficial pyoderma gangrenosum (SPG) that was successfully treated with infliximab. A 22-year-old man presented with several polycyclic, purplish red plaques with some crusting and well-defined edges on the bilateral lower extremities. Histology showed superficial and deep mixed inflammatory cell infiltrate with prominent neutrophils and scarring noted as a result of multiple sinus tract formations that were characteristic of SPG. After unsuccessful results with typical treatments (ie, steroids, antibiotics, immunosuppressants), the patient was successfully treated with infliximab.


 

Recommended Reading

Secukinumab Tames Hand, Foot Psoriasis
MDedge Dermatology
Oral JAK Inhibitor's Clinical Place To Be Determined
MDedge Dermatology
ACE Inhibitors Up Mortality Risk When Given Prior to Scleroderma Renal Crisis
MDedge Dermatology
Biologics May Reduce RA Patients' Risk of Early Death
MDedge Dermatology
Ustekinumab's Cardiovascular Event Rates Stable at 5 Years
MDedge Dermatology
Free Pharma Pens: The Skinny Podcast
MDedge Dermatology
Subcutaneous Nodules Linked to Cardiovascular Disease Risk in RA
MDedge Dermatology
Anti-Jo1 Predicts Improvement With Rituximab
MDedge Dermatology
Psoriasis Patients Have Low Rates of Common Cancers
MDedge Dermatology
308-nm UVB Excimer Laser Versus Nontargeted Phototherapy
MDedge Dermatology